UltraTech Cement rises 3.6% as HSBC, Jefferies retain Buy

UltraTech Cement Limited (ULTRACEMCO) shares rose as much as 3.6% on September 21, after HSBC and Jefferies both retained their Buy ratings. HSBC set a target of ₹14,200, Jefferies ₹14,065, against a share price near ₹11,000. HSBC's note specifically cited September's cement price increases as a factor that should let UltraTech pass on recent variable cost increases. The brokerage also pushed back directly against the stock's recent valuation de-rating, arguing the company's industry-leading volume growth, profitability, and market share remain intact, and that its pan-India scale should continue to command a valuation premium. Of 42 analysts covering the stock, 38 currently rate it Buy. Both brokerages are making a specific, checkable argument, that recent price weakness reflects a valuation de-rating the underlying business does not justify, not a deterioration in fundamentals. That is a stronger basis for a rating than a generic bullish call, since it names the exact gap between price action and business performance they are betting will close. The target prices imply roughly 27% upside from current levels, which is a meaningful gap for two large brokerages to back with Buy ratings simultaneously. What I want to see before treating this as confirmation rather than analyst optimism is whether September's cement price increases actually hold through the quarter, since HSBC's own thesis depends specifically on those price hikes sticking, not just being announced. My stance: two credible brokerages making a specific, testable argument, not a vague upgrade. Watching whether cement price increases actually hold through the quarter before treating the de-rating thesis as confirmed. I do not hold UltraTech Cement Limited at the time of writing.